The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker ...

EXCERPT: For a nation where consciousness about the need to shed weight in growing by the day, Eli Lilly's new weight-loss ...

Long before he found himself in the middle of a multibillion-dollar takeover battle for a coveted new weight-loss drug, Whit ...

The anti-obesity drug registered sales of ₹100 crore in October, unseating the previous best-selling antibiotic Augmentin, ...

Recent Gallup data shows a decline in U.S. obesity rates, likely linked to widespread use of GLP-1 drugs like Ozempic and Wegovy.

People taking GLP-1 meds could see costs drop in 2026, thanks to a new federal deal with Eli Lilly and Novo Nordisk, the ...

Prices are supposed to come down on weight loss drugs like Zepbound and Wegovy, but when will you see a change in your ...

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...

The guidance describes obese foreigners as a ‘public charge’ and orders visa officers to guess how much they would claim in ...

President Donald Trump’s deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

President Donald Trump announced major GLP-1 drug price cuts with Eli Lilly and Novo Nordisk, reducing costs for Ozempic and Wegovy.